Abilify

3 patent expirations in 2024 and how companies are pivoting
Pharma Voice
Wed, 04/17/24 - 11:13 am
patents
patent cliff
Bayer
J&J
Xarelto
Novo Nordisk
Victoza
Otsuka
Lundbeck
Abilify
Otsuka, Lundbeck gain FDA nod for longer-acting version of schizophrenia drug Abilify
Fierce Pharma
Mon, 05/1/23 - 10:04 am
Otsuka
Lundbeck
FDA
Abilify
Asimtufii
bipolar disorder
Did a blockbuster drug make hundreds gamble compulsively? A legal fight may decide what science can’t confirm
Stat
Thu, 08/2/18 - 12:36 pm
Abilify
compulsive behavior
Bristol-Myers Squibb
Otsuka
Lawsuit Claims Drug Abilify Causes Compulsive Gambling
Legal Scoops
Mon, 03/19/18 - 11:37 pm
Abilify
gambling
compulsive behavior
Bristol-Myers Squibb
Otsuka
First 'digital drug' faces a second litmus test: improving adherence
Medical Marketing and Media
Mon, 11/27/17 - 10:15 am
digital pills
drug adherence
Otsuka
Abilify
Proteus
Abilify MyCite
Proteus, Otsuka take another run at FDA approval for Abilify-smart pill combo
Drug Delivery Business News
Wed, 05/24/17 - 10:50 am
Proteus
Otsuka
FDA
Abilify
smart pills
3 Biggest Risks for Bristol-Myers Squibb in 2017
Motley Fool
Sun, 01/1/17 - 11:36 am
Bristol-Myers Squibb
Opdivo
Abilify
Bristol-Myers Squibb settles with Mass., other states over Abilify marketing
Bizjournals.com
Thu, 12/8/16 - 11:22 pm
Bristol-Myers Squibb
Abilify
antipsychotics
FDA Prevails in Otsuka Challenge to Scope of ABILIFY 3-Year Exclusivity, Leaving Intact ARISTADA 505(b)(2) NDA Approval
FDA Law Blog
Mon, 08/1/16 - 09:36 am
FDA
Otsuka
Abilify
exclusivity
Aristada
Alkermes
Commonly used drug can cause uncontrollable urge to gamble and have sex, FDA says
Stat
Tue, 05/3/16 - 09:53 pm
Abilify
antipsychotic
FDA
Otsuka
Bristol-Myers Squibb
FDA wants more from Proteus, Otsuka on ‘smart pill’
Mass Device
Wed, 04/27/16 - 10:04 pm
FDA
Proteus
Otsuka
Abilify
antidepressants
smart pills
Sovaldi is expensive, but this drug cost N.C. Medicaid even more
Bizjournals.com
Wed, 12/16/15 - 10:55 am
Sovaldi
Gilead Sciences
drug pricing
North Carolina
Medicaid
Otsuka
Abilify
Massive gov't study promotes smaller drug doses, more talk therapy for schizophrenia
BioPharma Dive
Tue, 10/20/15 - 05:56 pm
schizophrenia
Otsuka
Abilify
Novartis
Clozaril
Alkermes wins an FDA nod for its monthly schizophrenia drug
Fierce Biotech
Tue, 10/6/15 - 09:58 am
FDA
Alkermes
schizophrenia
Aristada
Abilify
FDA to review Proteus ‘smart pill’ with Otsuka’s Abilify anti-depressant
Mass Device
Fri, 09/11/15 - 10:46 am
FDA
Proteus
Otsuka
Abilify
antidepressants
devices
smart pills
Bam! Bam! Two Plaintiffs Fall in Two District Court Decisions Concerning Orphan Drug Exclusivity Carve-Outs
FDA Law Blog
Fri, 05/29/15 - 10:23 am
Otsuka
Abilify
orphan drugs
exclusivity
Fusilev
Spectrum Pharmaceuticals
Otsuka loses lawsuit challenging FDA approval of generic Abilify
Yahoo/Reuters
Thu, 05/28/15 - 02:00 pm
Otsuka
FDA
Abilify
generics
Teva Pharmaceutical
FDA takes aim at Abilify marketing material
Medical Marketing and Media
Wed, 04/29/15 - 06:35 pm
FDA
Abilify
Bristol-Myers Squibb
Will Schizophrenia and Bipolar Patients Trust Generic Abilify?
24/7 Wall St
Wed, 04/29/15 - 08:18 am
schizophrenia
bipolar disorder
generics
Abilify
Bristol-Myers Squibb
FDA approves generic versions of antipsychotic drug Abilify
Yahoo/Reuters
Tue, 04/28/15 - 09:05 pm
FDA
generics
Abilify
Bristol-Myers Squibb
antipsychotics

Pages